Company Overview and News

 
MSM Corporation International to reveal key appointment

2017-10-09 proactiveinvestors.com.au
MSM Corporation International Ltd (ASX:MSM) is an online entertainment company that specialises in building and launching new digital entertainment products.
Upvote Downvote

 
MSM Corporation launches talent competition app in the U.S. and Australia

2017-10-04 proactiveinvestors.com.au
MSM Corporation International Ltd (ASX:MSM) has released the Megastar app, available for download in Apple App Store and Google Play Store, in the U.S. and Australia.
Upvote Downvote

 
First Ever Global Mobile Talent Competition to Award $1 Million

2017-10-03 prnewswire
OAKLAND, Calif., Oct. 3, 2017 /PRNewswire/ -- Today, MEGASTAR announced the launch of their global talent competition with eight-time Grammy award winning superstar Usher as the Creative Director, Head Judge, mentor, and investor.  MEGASTAR is set to be the world's largest crowdsourced talent competition. The innovative mobile competition features performers of any category from around the world competing to win $1 million, a role in a film produced by John Baldecchi, and a variety of small cash prizes.
Upvote Downvote

 
MSM Corporation International bags A$10.5 million; ropes in Usher

2017-08-15 proactiveinvestors.com.au
MSM Corporation International (ASX:MSM) has successfully completed a capital raising of A$10.5 million via the issue of shares and convertible loans.
Upvote Downvote

 
MSM Corporation International bags A$10.5M; ropes in Usher

2017-08-14 proactiveinvestors.com.au
MSM Corporation International (ASX:MSM) has successfully completed a capital raising of A$10.5 million via the issue of shares and convertible loans.
Upvote Downvote

 
MSM Corporation International Ltd accelerates talent discovery competition

2016-09-26 proactiveinvestors.com.au
MSM Corporation International Ltd (ASX:MSM) has partnered with marketing platform ToneDen to support the launch of its Megastar Millionaire talent discovery competition. Megastar Millionaire is a talent discovery platform where artists and viewers connect with each other using a mobile app. As viewers are moving away from television to mobile, MSM is looking to create a mobile equivalent of ‘America's Got Talent’ and ‘American Idol’.
Upvote Downvote

 
MSM Corporation International Ltd to raise funds, accelerate product development

2016-09-12 proactiveinvestors.com.au
MSM Corporation International Ltd (ASX:MSM) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open. The company requested the halt pending details on the appointment of strategic advisors, and a capital raising. The halt will remain in place until the opening of trade on Wednesday 14th September 2016, or earlier if an announcement is made to the market.
Upvote Downvote

 
Megastar Millionaire: The global reality talent show that lets you be the judge

2016-08-05 smh.com.au
Fancy yourself as a judge on The Voice? Or as a producer on Big Brother, making calls about which contestants make the cut? Formulating the rules of the show. Hanging out with the stars. Choosing which projects are developed into shows. 
Upvote Downvote

 
MSM Corporation International Ltd primes its talent show platform

2016-06-27 proactiveinvestors.com.au
MSM Corporation International Ltd (ASX:MSM) formerly Minerals Corporation Ltd has entered into a binding term sheet to acquire 100% of Megastar Millionaire Pty Ltd (“MSM”), an online, mobile-first, music competition platform.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...